Skip to content

#AHA17: A Twitter Roundup

In This Article

  • Health care professionals at this year's American Heart Association's Scientific Sessions talked research, treatment approaches and guidelines on the podium and in conference halls
  • These conversations carried over onto Twitter, with nearly 200 million impressions and over 30,000 #AHA17 tweets

Healthcare professionals at this year’s American Heart Association’s Scientific Sessions discussed late-breaking research, innovative treatment approaches and brand new guidelines. The conversations carried over from the podium and conference halls onto Twitter, with nearly 200 million impressions and over 30,000 tweets.

Here is a list of some noteworthy #AHA17 tweets.

New Hypertension Guideline

The American Heart Association created buzz on Twitter and beyond with the announcement of their new hypertension guideline.



Poster Presentation

Mass General's Brian Ghoshhajra, MD, shared a poster by Jan-Erik Scholtz, MD, demonstrating improved results by following the newly revised 2017 Fleischner Society Guidelines.



A Systematic Review

JAMA released a systematic review showing the association of high-sensitivity cardiac troponin I concentration with cardiac outcomes in patients with suspected ACS.



Lifetime Risk of Atrial Fibrillation

Mass General's Steven Lubitz, MD, noted that the lifetime risk of atrial fibrillation in the Framingham Heart Study is around 37% after the age of 55.



The Fight Against Coronary Disease

Mass General's Jason Wasfy, MD, offered his well wishes to American Heart Association President John Warner, MD, as he recovers from a myocardial infarction, and reminded his followers of the work ahead to fight coronary disease.



Distinguished Scientist Award

Mass General's Sekar Kathiresan, MD, who was named an American Heart Association Distinguished Scientist at #AHA17, thanked his family, friends and followers for their kind words in response to his achievement.

Do you use Twitter to disseminate innovative treatment approaches and new data? Tell us about your experience with social media as a platform for discussing research in the comments below.

Refer a patient to the Corrigan Minehan Heart Center


At this year’s AHA Scientific Sessions, Maulik Majmudar, MD, cardiologist and associate director of the Healthcare Transformation Lab at Massachusetts General Hospital, chairs the day-long Health Tech Summit. Dr. Majmudar answers some questions about the importance of health technology and the role it plays at conferences like the Scientific Sessions.